Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco.
Adolescent
Adult
Bordetella pertussis
/ genetics
Child
Child, Preschool
Cross-Sectional Studies
DNA, Bacterial
/ analysis
Diagnostic Tests, Routine
Enzyme-Linked Immunosorbent Assay
Female
Humans
Infant
Infant, Newborn
Male
Morocco
/ epidemiology
Mothers
Nasopharynx
/ microbiology
Pertussis Toxin
/ immunology
Prevalence
Real-Time Polymerase Chain Reaction
Serologic Tests
Whooping Cough
/ diagnosis
Anti-PT IgG/IgA
B. Parapertussis
B. holmesii
Household contacts
Pertussis
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
14 Jan 2020
14 Jan 2020
Historique:
received:
30
04
2019
accepted:
29
11
2019
entrez:
16
1
2020
pubmed:
16
1
2020
medline:
9
4
2020
Statut:
epublish
Résumé
In recent decades, there has been a marked increase in the number of reported cases of pertussis around the world, and pertussis continues to be a frequently occurring disease despite an effective childhood vaccination. This study aims to determine the role of household contacts of children diagnosed with pertussis in Casablanca Morocco. From November 2015 to October 2017, children suspected of whooping cough that consulted Ibn Rochd University hospital at Casablanca with their household contacts were enrolled in the study. Nasopharyngeal (NP) samples of the suspected children were analyzed by culture and RT-PCR. For the household contacts, NP and blood samples were collected and analyzed by RT-PCR and specific detection of pertussis toxin antibodies by ELISA, respectively. During the study period, the survey was carried out on 128 infants hospitalized for pertussis suspicion and their families (N = 140). B. pertussis DNA was specifically detected in 73 (57%) samples, coexistence of B. pertussis and B. parapertussis DNA in 3 (2.3%) samples, coexistence of B. pertussis and B. holmesii DNA in 10 (7.81%) and only one (0.78%) sample was IS 481 RT-PCR positive without the possibility of determining the Bordetella species with the diagnostic tools used. Confirmations of Pertussis infection in household contacts by culture, RT- PCR and serology were 10, 46 and 39%, respectively. B. pertussis DNA was confirmed in the infants as well in their mothers in 38% of the cases. Co detection of B. pertussis and B. parapertussis DNA in 2% and co-detection of B. pertussis and B. holmesii DNA in 4%. B. holmesii DNA alone was detected in 5 NP samples of index cases and their mothers. The results of this study confirm that B. pertussis is still circulating in children and adults, and were likely a source of pertussis contamination in infants still not vaccinated. The use of RT-PCR specific for B. pertussis in the diagnosis of adults is less sensitive and should be associated with serologic tests to improve diagnosis of pertussis and contributes to preventing transmission of the disease in infants.
Sections du résumé
BACKGROUND
BACKGROUND
In recent decades, there has been a marked increase in the number of reported cases of pertussis around the world, and pertussis continues to be a frequently occurring disease despite an effective childhood vaccination. This study aims to determine the role of household contacts of children diagnosed with pertussis in Casablanca Morocco.
METHODS
METHODS
From November 2015 to October 2017, children suspected of whooping cough that consulted Ibn Rochd University hospital at Casablanca with their household contacts were enrolled in the study. Nasopharyngeal (NP) samples of the suspected children were analyzed by culture and RT-PCR. For the household contacts, NP and blood samples were collected and analyzed by RT-PCR and specific detection of pertussis toxin antibodies by ELISA, respectively.
RESULTS
RESULTS
During the study period, the survey was carried out on 128 infants hospitalized for pertussis suspicion and their families (N = 140). B. pertussis DNA was specifically detected in 73 (57%) samples, coexistence of B. pertussis and B. parapertussis DNA in 3 (2.3%) samples, coexistence of B. pertussis and B. holmesii DNA in 10 (7.81%) and only one (0.78%) sample was IS 481 RT-PCR positive without the possibility of determining the Bordetella species with the diagnostic tools used. Confirmations of Pertussis infection in household contacts by culture, RT- PCR and serology were 10, 46 and 39%, respectively. B. pertussis DNA was confirmed in the infants as well in their mothers in 38% of the cases. Co detection of B. pertussis and B. parapertussis DNA in 2% and co-detection of B. pertussis and B. holmesii DNA in 4%. B. holmesii DNA alone was detected in 5 NP samples of index cases and their mothers.
CONCLUSIONS
CONCLUSIONS
The results of this study confirm that B. pertussis is still circulating in children and adults, and were likely a source of pertussis contamination in infants still not vaccinated. The use of RT-PCR specific for B. pertussis in the diagnosis of adults is less sensitive and should be associated with serologic tests to improve diagnosis of pertussis and contributes to preventing transmission of the disease in infants.
Identifiants
pubmed: 31937256
doi: 10.1186/s12879-019-4680-1
pii: 10.1186/s12879-019-4680-1
pmc: PMC6961324
doi:
Substances chimiques
DNA, Bacterial
0
Pertussis Toxin
EC 2.4.2.31
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
43Références
Int J Infect Dis. 2015 Dec;41:36-41
pubmed: 26523641
Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):307-12
pubmed: 21069406
Clin Vaccine Immunol. 2012 Jan;19(1):64-72
pubmed: 22116688
BMC Infect Dis. 2017 May 16;17(1):348
pubmed: 28511667
BMC Infect Dis. 2013 Mar 11;13:129
pubmed: 23496900
Clin Infect Dis. 2012 Jun;54(12):1756-64
pubmed: 22431797
Clin Microbiol Infect. 2011 Mar;17(3):365-70
pubmed: 20456454
Vaccine. 1998 Dec;16(20):1907-16
pubmed: 9796042
J Clin Microbiol. 2011 Dec;49(12):4059-66
pubmed: 21940464
Clin Infect Dis. 2006 Jul 15;43(2):151-7
pubmed: 16779740
Vaccine. 2013 Jan 11;31(4):618-25
pubmed: 23200883
J Med Microbiol. 2019 Feb;68(2):241-247
pubmed: 30526740
Int J Infect Dis. 2010 Feb;14(2):e111-4
pubmed: 19559636
Clin Infect Dis. 2013 Feb;56(3):322-31
pubmed: 23087388
J Hosp Infect. 2012 Oct;82(2):133-5
pubmed: 22940441
J Clin Microbiol. 2010 Dec;48(12):4459-63
pubmed: 20943873
Chest. 2014 Jul;146(1):205-214
pubmed: 25010963
Epidemiology. 2012 Nov;23(6):852-60
pubmed: 23018969
J Clin Microbiol. 2001 May;39(5):1963-6
pubmed: 11326023
J Clin Microbiol. 2005 Oct;43(10):4925-9
pubmed: 16207944
Pediatrics. 2015 Oct;136(4):635-41
pubmed: 26347437
Diagn Microbiol Infect Dis. 2014 Mar;78(3):302-6
pubmed: 24355701
Pediatr Infect Dis J. 2004 Nov;23(11):985-9
pubmed: 15545851
Clin Microbiol Rev. 2005 Apr;18(2):326-82
pubmed: 15831828
Vaccine. 2015 Sep 11;33(38):4756-61
pubmed: 26277068
J Clin Microbiol. 2011 Dec;49(12):4347-8
pubmed: 22012009
Eur J Clin Microbiol Infect Dis. 2013 Jan;32(1):89-96
pubmed: 22886091
BMJ. 2013 Jul 17;347:f4249
pubmed: 23873919
Expert Rev Anti Infect Ther. 2016 Jul;14(7):657-67
pubmed: 27224518
N Engl J Med. 2012 Aug 30;367(9):785-7
pubmed: 22894554
Wkly Epidemiol Rec. 2014 Jul 25;89(30):337-40
pubmed: 25072068